Johnson & Johnson today announced it broke ground on a $2 billion biologics manufacturing facility in Wilson, N.C., a small portion of the company’s $55 billion U.S. investment initiative over the next four years. The 500,000 ft² facility will expand the company’s capacity to develop and produce advanced therapies for oncology, immunology and neurological diseases.…
FDA approves additional manufacturing sites for Currax Pharma
Currax Pharmaceuticals today announced the FDA approved a second manufacturing site for its Contrave medication. The approval of the second site enhances the production capacity for the company’s oral weight loss medication, also marketed as Mysimba in Europe. Currax said it is investing in manufacturing and advancing clinical research. “At Currax, we are steadfast in…
Getinge launches manual, externally openable port for pharma manufacturing
Getinge recently launched its DPTE-FLEX manual, externally openable port for pharmaceutical manufacturing. The company designed the port to enhance safety, efficiency and compliance. It allows for secure, gloveless transfers to reduce human intervention and contamination risks. “The external handles of the DPTE-FLEX perform dual functions — unlocking/locking and opening/closing – all accessible from outside the…
J&J invest $2B to build new manufacturing facility in North Carolina
Johnson & Johnson recently announced plans to invest more than $2 billion in a new manufacturing facility in North Carolina. The company plans to build a state-of-the-art biologics manufacturing facility in Wilson, North Carolina, to expand the production of its pipeline of innovative biologics. The expansion supports J&J’s broader plan to advance more than 70…
Roche opens pharma R&D facility in Switzerland
Roche recently announced it opened its latest Pharma Research and Early Development (pRED) Center in Basel Switzerland. The new facility is equipped with cutting-edge technologies and houses around 1,000 laboratory and office workspaces, according to the company. It is located at the company’s global headquarters and brings together teams of scientists and researchers to accelerate…
Mispro announces latest vivarium lab space in Boston
Mispro this week announced it will open its tenth Boston facility in December. The contract vivarium organization’s newest Boston-based facility will be located on Binney Street in Kendall Square, Cambridge, Massachusetts. The company said that Kendall Square has been recognized as a biotechnology and pharmaceutical innovation hub. Mispro’s latest facility will have turnkey vivarium lab…
Eugia Pharma receives OAI classification from FDA following sterile production inspections
Eugia Pharma Specialties’ manufacturing hub in India has received an FDA warning letter based on inspections of its facility. The new warning letter is tied to previous warnings about the company’s Unit III Formulation manufacturing facility. The unit makes terminally sterilized products. Eugia’s Hyderabad, India-based facility received an official action indicated (OAI) status notice in…
Novo Nordisk invests $4.1B to expand manufacturing operations in North Carolina
Novo Nordisk today announced plans to invest $4.1 billion to build a new manufacturing facility in North Carolina. The Denmark-based company will build a second fill and finishing manufacturing facility in Clayton, North Carolina, to grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases. Novo…
Emergent BioSolutions sells Baltimore manufacturing plant to Bora for $30M
Emergent BioSolutions this week announced it entered into a definitive agreement to sell its Baltimore-Camden drug product facility. The Gaithersburg, Maryland-based company will sell the facility to an affiliate of Bora Pharmaceuticals for approximately $30 million. Emergent’s Camden site is part of the company’s Contract Development and Manufacturing Organization (CDMO) and has clinical and commercial…
Thermo Fisher Scientific expands clinical research lab in Wisconsin
Thermo Fisher Scientific has expanded its clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin. The new $58 million investment adds 72,500 sq ft. to the company’s footprint and increases the site’s chemistry, manufacturing, and control analytical capabilities for biopharmaceutical therapy development. “As research in biopharmaceutical therapies continues to rapidly…